2,885
Participants
Start Date
August 31, 2007
Primary Completion Date
July 31, 2011
Study Completion Date
June 30, 2013
LCS12
Intrauterine system (IUS) with Levonorgestrel, in vitro releasing rate 12 microg/24 h
LCS16
Intrauterine system (IUS) with Levonorgestrel, in vitro releasing rate 16 microg/24 h
Budapest
Kolbotn
Lanús Oeste
Rosario
Elverum
Esztergom
Larvik
Eger
Nyíregyháza
Békéscsaba
Kecskemét
Szentes
Szeged
Trondheim
New York
México, D.F.
Lahti
Pittsburgh
Jenkintown
Philadelphia
Turku
Turku
Turku
Quetigny
Norfolk
Torreón
Winston-Salem
New Bern
Columbia
Nîmes
Decatur
Atlanta
Jacksonville
Tampere
Miami
West Palm Beach
Boyton Beach
Mobile
Nashville
Chattanooga
Grenoble
Memphis
Roanne
Columbus
Cincinnati
South Bend
Evansville
Kotka
Kalamazoo
Reims
Chaska
Lille
Compiègne
Chicago
Chesterfield
Lincoln
Marrero
Kuopio
Örebro
Uppsala
Houston
Houston
Le Chesnay
Austin
Joensuu
Littleton
Denver
Hermosillo
Idaho Falls
Boise
Phoenix
Glendale
Tucson
Albuquerque
Las Vegas
Las Vegas
Las Vegas
Oulu
Umeå
Oulu
Pacific Palisades
Torrance
Oulu
San Diego
San Diego
San Diego
San Diego
Carmichael
Portland
Medford
Seattle
Spokane
Boston
Moorestown
New Brunswick
Pittsburgh
San Isidro
Buenos Aires
Calgary
Winnipeg
Winnipeg
Kingston
London
Waterloo
Montreal
Montreal
Québec
Québec
Shawinigan
Sherbrooke
Saskatoon
Santiago
Monterrey
Espoo
Helsinki
Helsinki
México, D.F.
México, D.F.
Alkmaar
Eindhoven
Heerlen
Helmond
Hoofddorp
Nijmegen
Rotterdam
The Hague
Utrecht
Oslo
Gothenburg
Luleå
Malmo
Norrköping
Stockholm
Stockholm
Stockholm
Stockholm
Lead Sponsor
Bayer
INDUSTRY